首页> 外文期刊>Medical oncology >MicroRNA-542-3p suppresses cell growth of gastric cancer cells via targeting oncogene astrocyte-elevated gene-1
【24h】

MicroRNA-542-3p suppresses cell growth of gastric cancer cells via targeting oncogene astrocyte-elevated gene-1

机译:MicroRNA-542-3p通过靶向癌基因星形胶质细胞升高的基因-1抑制胃癌细胞的生长

获取原文
获取原文并翻译 | 示例
           

摘要

MicroRNAs (miRNAs) have been suggested to play critical roles in tumorigenesis as well as in the development of therapies for the treatment of cancers. However, the tumor-associated miRNAs in gastric cancers remain poorly understood. Here, we report on miR-542-3p in gastric cancers, which has been widely studied in other cancers as a tumor suppressor. Real-time quantitative PCR analysis demonstrated that miR-542-3p was significantly down-regulated in gastric cancer tissues (p < 0.0001) and cell lines (p < 0.001). Overexpression of miR-542-3p significantly inhibited cell growth of gastric cancer cells both in vitro (p < 0.01) and in vivo (p < 0.01). Notably, overexpression of miR-542-3p apparently reduced the protein expression of astrocyte-elevated gene-1 (AEG-1) (p < 0.01). The dual-luciferase reporter assay validated that miR-542-3p directly bound the 3 '-untranslated region (UTR) of AEG-1, which could be abolished by mutation of the predicted miR-542-3p binding site. Furthermore, overexpression of miR-542-3p markedly inhibited the activation of oncogenic signaling pathways including the Akt, beta-catenin and nuclear factor-kappa B pathways. Additionally, overexpression of AEG-1 without the 30-UTR partially reversed the cell growth arrest induced by miR-542-3p overexpression in gastric cancer cells (p < 0.05). Taken together, these data suggest that miR-542-3p might function as a tumor suppressor in gastric cancer, potentially by targeting the oncogene AEG-1, implying a potential role for miR-542-3p in the development of therapeutic methods for gastric cancer.
机译:有人建议MicroRNA(miRNA)在肿瘤发生以及癌症治疗方法的开发中起关键作用。但是,胃癌中与肿瘤相关的miRNA仍然知之甚少。在这里,我们报道了miR-542-3p在胃癌中的应用,而miR-542-3p在胃癌中作为抑癌剂已被广泛研究。实时定量PCR分析表明,miR-542-3p在胃癌组织(p <0.0001)和细胞系(p <0.001)中显着下调。 miR-542-3p的过表达在体外(p <0.01)和体内(p <0.01)均显着抑制胃癌细胞的细胞生长。值得注意的是,miR-542-3p的过度表达明显降低了星形胶质细胞升高的基因1(AEG-1)的蛋白表达(p <0.01)。双重荧光素酶报告基因测定证实,miR-542-3p直接结合AEG-1的3'-非翻译区(UTR),这可以通过预测的miR-542-3p结合位点的突变而消除。此外,miR-542-3p的过表达显着抑制了致癌信号通路的激活,包括Akt,β-catenin和核因子-κB通路。另外,在没有30-UTR的情况下AEG-1的过表达部分逆转了miR-542-3p过表达在胃癌细胞中诱导的细胞生长停滞(p <0.05)。综上所述,这些数据表明,miR-542-3p可能通过靶向癌基因AEG-1来作为胃癌的抑癌药,这暗示miR-542-3p在胃癌治疗方法的开发中具有潜在的作用。 。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号